Home
Patients & Families
Careers
Contact Us
Navigate Adaptimmune Limited
Home
Our Company
Overview
Board of Directors
Management & Founders
Partners
Pipeline
Pipeline Overview
MAGE-A10 TCR
AFP TCR
MAGE-A4 TCR
NY-ESO TCR
Technology
Our Strengths
The Immune System
Our Engineered T-Cell Therapies
Our Technology Platform
Manufacturing
Intellectual Property
Publications
News & Events
News
Scientific Conferences
Investor Conferences
Investors
Enhancing the affinity of T-cells to fight cancer
Learn More
Our Goal is to Help Cancer Patients Reach Theirs
Resources for Patients
Our Technology
Our Company
Investor & Financial Information
Meet Us At
June 1, 2018 – June 5, 2018
Scientific Event: American Society of Clinical Oncology (ASCO) Annual Meeting
Latest News •
View all
May 16, 2018
Myxoid/Round Cell Liposarcoma Data with NY-ESO and MAGE-A10 Study Update to be Presented at American Association for Clinical Oncology (ASCO) Annual Meeting
May 9, 2018
Adaptimmune Reports First Quarter 2018 Financial Results and Business Update
April 25, 2018
Adaptimmune to Report First Quarter 2018 Financial Results and Business Update on Wednesday May 9, 2018
